NeuroScience Research Center, LLC.

06/01/2026

Join us this June to raise awareness, support families, and advance research toward a world without Alzheimer's.

05/04/2026

Canton neurologist among first in US to use blood test for early Alzheimer’s detection

https://www.cleveland19.com/2026/04/30/canton-neurologist-among-first-us-use-blood-test-early-alzheimers-detection/

04/28/2026

IDIOPATHIC HYPERSOMNIA

The path forward for idiopathic hypersomnia starts with new research. Consider the ONSTRIDE-2 study.

330-244-2542
www.neuroscienceresearchcenterllc.com

03/10/2026

02/05/2026

If you are living with narcolepsy type 1 (NT1), narcolepsy type 2 (NT2), or idiopathic hypersomnia (IH), the Vibrance Studies may be an opportunity to contribute to important research of an investigational treatment option.

Visit www.neuroscienceresearchcenterllc.com
or
Call 330-244-2542

10/15/2025

Neuroscience Research Center, LLC is a neurology focused clinical research company concentrated on advancing the treatment of our patients. Bringing innovative research opportunities to Northeast Ohio, we aim to enhance the lives of the patients we c

07/18/2025

We received a beautiful bouquet from one of our appreciative patients - a heartfelt thank you in the symbolic purple of Alzheimer's awareness. Gestures like these remind us why we do what we do.

06/05/2025

June is Alzheimer’s & Brain Awareness Month! Repost to raise awareness for the more than 55 million people worldwide impacted by Alzheimer’s and other dementia. Take action at alz.org/abam.

04/08/2025

Introducing cAPPricorn-1, a clinical trial for people with cerebral amyloid angiopathy (CAA) that is currently enrolling participants.
The cAPPricorn-1 clinical trial is researching an investigational medication called mivelsiran to see if it could be safe and effective in slowing the progression of CAA.

To learn more, please contact us at 330-244-2542 or
visit www.neuroscienceresearchcenterllc.com